Introduction
Rheumatoid arthritis (RA) is a systemic chronic autoimmune disease. Synovial tissue, normally consisting of mesenchymal fibroblasts and bone marrow-derived macrophages, undergoes many changes in affected RA joints: the synovial lining and sublining become infiltrated with blood leucocytes, synovial fibroblast-like cells from the lining and sublining become activated and hyperproliferative, which together with neovascularization results in granulomatous pannus formation. 1, 2 In addition, local complement activation, activation of the coagulation cascade and proteinase expression are all observed in the RA synovium and contribute to bone and cartilage destruction. The diagnosis of RA is difficult because of the lack of an etiologic agent and because there is no unique clinical or laboratory feature that distinguishes RA from other joint diseases. Therefore, the diagnosis is based on a set of seven parameters: five clinical parameters, supplemented with radiographic evidence of joint destruction and the presence of serum rheumatoid factor (antibodies to the Fc part of IgG molecules). 3 A patient is diagnosed with RA when four out of these seven criteria are met. The treatment of RA is mainly focused at reducing inflammation and pain control. The most effective treatment currently used is neutralization of TNFa. However, approximately onethird of the patients do not respond to this treatment. 4 Likewise, there is a large interindividual variation in clinical response to methotraxate 5 and NSAID's. 6 The clinical presentation, diagnostic criteria, and variance in treatment response indicate that RA is a heterogeneous disease. The heterogeneous character of RA is confirmed by the wide variation in cytokine synthesis in the synovial membrane among patients with RA 7 and the interindividual differences in organization of infiltrated immune cells in RA synovium. 8, 9 In an initial study using a selected subset of immune system genes, we found molecular evidence for subclassification of rheumatoid synovia. In this study, we made an attempt to subclassify RA patients based on the global expression of genes in affected synovial tissue from individual RA patients by cDNA microarray technology.
Results
We isolated mRNA from 15 different RA tissues, which were labeled and hybridized to microarrays containing approximately 24 000 cDNA spots (one tissue was labeled and hybridized twice). For our analysis, we selected those genes whose transcripts varied in abundance by at least two-fold from their median level in at least four tissues.
Hierarchical clustering 10 of those genes resulted in a subclassification of RA patients into two main groups with distinct expression profiles (Figure 1) . The most striking difference between the groups is the level of expression of immune-related genes. One group (RA-I) is characterized by tissues showing a high inflammatory gene expression signature (Figure 2 ). In this group of 10 RA tissues, a number of highly expressed genes indicate the specific activity of B and T cells: several immunoglobulin-encoding genes, genes encoding for the B-cell marker CD79B, the B-cell activator and lymphoid tissue expressed gene BLAME, molecules that constitute the TCR signaling complex; CD3 d, T-cell-R a, -b and -d locus-and lck. Other genes reflect the sensitivity for cytokines such as the IL-2R common g-chain, the IL-7R, stat1 and the cytokine/stat-activation pathway-induced gene SSI3. In addition, a number of genes that are required for lymph node development were expressed by these tissues: DOCK2, SDF1, CXCR4, MIP1a, TNFSF13b/BLyS, IP-10, L-selectin and CD8. Other genes indicative for an ongoing immune response were the HLA class II encoding genes and other IFNg-induced genes such as IFI30 and IRF1. These results confirmed and extend our previous gene expression profiling study on synovial tissues using another set of microarrays with immune system selected genes (designated the lymphochip 37 ). Within this group two subgroups could be identified. One RA subgroup (RA-Ia, red branch) consisted of four different tissues that showed a high expression of immunoglobulin genes and other genes involved in the adaptive immune response. The RA-Ib group (six different tissues, green branch), like the RA-Ia group, showed a high expression of immunoglobulin genes but a lower expression of other genes involved in the adaptive immune response. In contrast, the RA-Ib group showed signs of activation of the classical pathway of complement activation ( Figure 3 ) C1Q a, C1Q b, C2 and C1R and an inhibitor of complement lysis, clusterin. Another prominent feature of the RA-Ib group was the high expression of genes involved in the production and degradation of extracellular matrix components such as syndecan, cartilage acidic protein, tetranectin and the matrix metalloproteinases mmp15 and mmp2.
The other main group, RA-II (blue branch), consisting of five different tissues showed a relative low expression of genes involved in inflammation and complement activation. Instead, these tissues revealed a higher expression of genes indicative for fibroblast dedifferentiation. The RA-II tissues expressed higher levels of several types of collagen, with collagen type II and XI most exclusively in the RA-II tissues (Figure 3b ).
Both the RA-Ib and RA-II group of tissues expressed a set of genes ( Figure 4 ) that are involved in tissue remodeling. Particularly interesting are the genes involved in the wnt signaling pathway. Wnt5a is expressed at higher levels in these tissues and is involved in the activation of the frizzled/wnt signaling pathway, which is important for embryonal morphogenesis. Other players in the wnt signaling, secreted frizzled related protein 2 (SFRP2) and Dickkopf homologue 3 (DKK3) may be negative regulators of this pathway. Activation of this pathway suggests that these tissues are subject to morphological changes.
We next analyzed which of the genes show statistically different expression levels between the two main tissue groups by Significance Analysis of Microarray data (SAM, Tables 2 and 3). A set of 160 distinct genes with a q-value o5% discriminated between RA-I and RA-II. In the RA-I group, 121 genes were expressed at higher levels, while the RA-II group showed 39 genes that were expressed at higher levels. The distinction between immune-and nonimmune-related genes is immediately obvious from these tables as well. In addition to the genes already mentioned in the cluster analysis, a number of new genes appeared that were filtered out by the clustering criteria: for instance the cytokines IL-16, and TGFb1, the IL-18R1, and the metalloproteinase mmp3 were expressed at higher levels in the RA-I group.
Another interesting aspect of this study is the fact that out of the 121 genes that were expressed at higher levels in RA-I compared to RA-II, nine genes were located at the chromosome 6p21.3 region. These genes are: HSPA1A heat-shock 70 kDa protein 1A, BF B-factor/ properdin, TAP1 ¼ peptide transporter, AIF1, PSMB8 ( ¼ LMP7 large molecular weight proteasome), P5-1 MHC class I region ORF T58146, and the GABBR1 (gaminobutyric acid B receptor 1), the HLA-DRB1 gene and the HLA-DPa chain. The other 116 genes were scattered throughout the genome, except for the 1q21-23 region (six genes) and the 11q22-25 and 14q11.1-2 regions (both five genes). Of the 39 genes that were expressed at significantly higher levels in the RA-II group, none were located at chromosome 6p21. 
Discussion
In this report, we analyzed large-scale expression of genes from affected synovial tissue from late stage RA patients, which revealed organized clusters of genes that are indicative for distinct pathological mechanisms in the different tissues. The most clear distinction was based on differences in expression between an immune-mediated profile in one group (RA-I), and a tissue remodeling profile in the other group of tissues (RA-II).
Immune activation pathway in RA-I tissues The MHC locus, harboring the HLA and TNFa genes and accounts for one-third of the genetic influence on the development of RA, 11 is actively transcribed in the RA-I group. Based on the estimated percentage of 0.7% of all genes that are mapped to this locus, 12 this probably reflects an over-representation of expressed genes from this region, as nine of the 121 (7.4%) genes overexpressed in the RA-I group were located at the HLA locus. The majority of these genes (five out of nine) is involved in antigen processing and presentation. Interestingly, for hsp70 a promoter polymorphism is identified that is associated with RA.
13
hsp70 is able to bind to the common motif shared by HLA-DR4 and HLA-DRB1, which is associated with the severity of RA.
14 The combined expression of hsp70 and HLA-DRB1 along with other genes important for antigen presentation in the RA-I group supports the hypothesis that autoantigens may drive the ongoing immune response in these tissues. Recently, it has been shown that about 25% of the RA tissues contain cellular infiltrates that have formed organized structures highly similar to the structures observed in lymph nodes, comprising follicular dendritic cells, T-and B-cell areas with germinal center formation. 8, 15 Interestingly, several genes important for normal lymph node development were expressed in the RA-I tissues. In general, the RA-I tissues showed a high degree of T-and B-cell activation, with additional expression of genes indispensable for lymph node development (Figure 2a and b, and Table 3 ) that is, DOCK2 16 and B lymphocyte stimulator (BlyS, TNFSF13b). 17 Here we confirmed the increased expression of the chemokines IP-10 and SDF1 and its ligand CXCR4, 18 important for lymph node development, in tissues with increased immune activity as was determined by expression profiling using the so-called lymphochip 37 ). CD8a was expressed at higher levels in the RA-Ia and to a lesser extent also in RA-Ib, whereas the CD4 antigen was expressed at equal levels in all patients (data not shown). This is especially interesting in light of the recent unexpected observation that CD8+ T cells are required to maintain lymphoid structures with germinal centers in RA tissue transplants in SCID mice. 15 Adhesion molecules are also important in lymph node development, in particular L-selectin, 19 which is also overexpressed in the RA-Ia group. In general, the RA-Ia group was the most extreme and showed the most homogeneous expression of these genes among patients. Therefore, this profile is expected to reflect the presence of ectopic germinal centers in the synovial tissue, which comprise 27% of the tissues and contribute to the pathology by increasing antibody formation and affinity maturation. Further studies are required to replicate and validate these findings by histological studies with a focus on lymphocytic infiltrates and the formation of germinal centers. This is subject of our current investigations on histologically well-defined tissue biopsies that will be analyzed on a new set of gene expression arrays.
Complement activation
The RA-Ib tissues expressed genes that encode for C1 proteins of the classical pathway of complement, which are known to be expressed by monocytes and synovial fibroblasts. 20 This could constitute an important pathway of tissue destruction, especially in combination with the high expression of immunoglobulins in these tissues, which are able to activate the classical pathway of complement, when complexed to antigens. The RA-Ia group, on the other hand, expressed genes encoding for proteins of the alternative pathway of complement, properdin (secreted by monocytes) 21 and factor I (secreted by fibroblasts and endothelial cells). This is rather surprising since the RA-Ia tissues also show a high expression of immunoglobulin genes. The same phenomenon was observed in monoclonal IgG1/anti-GPIinduced arthritis in mice, in which (unexpectedly) the alternative pathway of complement was activated. 22 This was probably because of the very poor activity of IgG1 to activate the classical pathway of complement. It was suggested that aggregated IgG binds to spontaneously activated circulating C3b thereby preventing its otherwise rapid degradation. Additional binding of properdin to this complex further stabilizes C3b, allowing it to activate the alternative pathway of complement. It is conceivable that this pathway is also active in the RA-Ia group.
Except for the RA-Ia tissues, all samples showed tissue remodeling activity with distinct features:
High turnover of matrix molecules in the RA-Ib group The RA-Ib group showed an increased expression of (potential) extracellular matrix molecules, such as tetranectin, syndecan and cartilage acidic protein and the enzymes that degrade matrix molecules, matrix metalloproteinases mmp15 and mmp2. Cartilage acidic protein is a potential extracellular matrix molecule that is normally expressed in bone and cartilage. 23 Therefore, its expression in synovial tissue suggests a disregulation of gene expression in synovial cells. MMP-15 is able to degrade several matrix molecules, is involved in TNFa processing and activates proMMP-2. In concert with the enhanced expression of MMP-2 (gelatinase A) these proteinases may contribute to the cartilage breakdown in this subset of tissues.
Fibroblast dedifferentiation
In the RA-II group, we selectively observed increased levels of several collagens, including collagen type II, characteristic for chondrocytes. Fibroblasts are able to differentiate into many different cell types, including cartilage and bone cells. It has been reported that synoviocytes located in the RA pannus region show characteristics of both fibroblasts and chondrocytes, indicated by the expression of collagen type II. 24 Here we see another marker for chondrocytes, sox9, selectively expressed by the RA-II tissues. Sox9 is an HMG-box class DNA-binding protein that is essential for chondrocyte differentiation and regulates the expression of genes involved in chondrogenesis by acting as a transcription factor for collagen types II and XI. 25 The only collagens that reached statistically significant higher levels in the RA-II group compared to the RA-I group were indeed collagen types II and XI (Table  2) . Therefore, sox9 may be important for the proposed transition of the fibroblast-like synoviocyte to a cell with chondrocyte characteristics. This could be considered an unbalanced rescue pathway to repair the destructed cartilage.
In contrast, in the RA-I tissues, fibroblasts appear to behave totally different and may perpetuate the chronic inflammatory process by expression of SDF-1 ( Figure  2a) , 26 which leads to the attraction and retention of lymphocytes, monocytes and dendritic cells.
Tissue repair and remodeling
Genes indicative for tissue repair were expressed in all tissues except the RA-Ia group. Osteoglycin and osteoprotegerin (OPG, the soluble decoy receptor for OPGL or RANKL) both inhibit osteoclast formation, 27, 28 and are likely expressed in an attempt to rescue destruction of the bone. Cartilage repair could be mediated by SPARC (osteonectin), an extracellular matrix protein involved in cartilage synthesis, which is overproduced by synovial cells from RA tissues. 29 Another class of tissue remodeling genes that is expressed at higher levels in these tissues is represented by genes encoding for proteins involved in wingless (wnt) signalling; wnt5a, Secreted Frizzled-related protein 2 (SFRP2), and Dickkopf homologue 3 (DKK3). The wnt signaling pathway has been characterized in drosophila and is important for embryonic limb development, cell growth and differentiation and its expression is developmentally regulated in a precise temporal and spatial manner. Wnt5a is a secreted protein that binds to the G protein linked receptor fz5. 30 Cultured fibroblast-like synovial cells from many RA patients maintain an activated phenotype after several cell divisions. The wnt signaling pathway is playing a role in this activation as blockage of wnt5a signaling in fibroblast-like synoviocytes from RA tissue inhibits activation in terms of cytokine production and OPGL expression. 31 Tightly controlled expression of agonists and antagonists of the wnt signaling pathway is crucial for tissue differentiation as is observed for DDK-1, a potent antagonist of wnt signaling controlling head formation in Xenopus. 32 The expression of the wnt antagonists DKK3 and SFRP-2 33 indicates that synovial cells are undergoing developmental changes in those tissues with little immune activation. It has been suggested before that synoviocytes may perpetuate disease by an autonomous growth and activation process in late stage RA. 2 Our data support and extend this hypothesis by identification of the genes involved in activation and dedifferentiation of synoviocytes.
In terms of clinical variables we found no differences in age, disease duration, laboratory measurements, or medication between the three groups of patients, indicating that different pathological processes that are active in late stage RA may not be easily recognized clinically.
In conclusion, these data show that distinct patientspecific molecular portraits with evidence for several different pathways of destruction and repair of bone and cartilage exist in late stage RA that may require different treatment strategies. For gene expression profiling by DNA microarray analysis, fluorescent cDNA probes were prepared from 1 mg experimental mRNA sample by oligo dT-primed polymerization using Superscript II reverse transcriptase in the presence of Cy-5 labeled dCTP as described (website: http:/ /cmgm.stanford.edu/pbrown/protocols. html). A common reference mRNA sample that consists of a mixture of mRNAs isolated from 11 different cell lines 34 was labeled with Cy-3. The use of a common reference cDNA probe allows the comparison of the relative expression levels across the tissue samples.
Microarray procedures DNA microarray analysis was done essentially as described by Eisen et al. 10 The Cy-5 labeled experimental cDNA and the Cy-3 labeled common reference sample were pooled and hybridized to the microarrays in a volume of 25 ml under a 22 Â 14 mm glass cover slip for 16 h at 651C and washed at a stringency of 0.2 Â SSC. The SH cDNA microarrays containing approximately 24 000 cDNA spots representing a random set of genes were used. Fluorescent images of hybridized microarrays were obtained using a genepix 4000 microarray scanner (Axon Instruments Inc., Union City, CA, USA). Images were analyzed with Genepix3.0 and fluorescence ratios were stored in a custom database. Fluorescent ratios were calibrated independently for each array by applying a single scaling factor to all fluorescent ratios from each array; this scaling factor was computed so that the mean fluorescent ratio of the measured spots on each array was equal to 1.0.
Data analysis
All nonflagged array elements for which the fluorescent intensity in each channel was greater than 1.6. times the local background were considered well measured. The ratio values were log-transformed (base 2) and stored in a table (rows, individual cDNA clones; columns, single mRNA species). cDNA spots that fulfilled the intensity criteria on at least 80% of the microarrays were analyzed. Data for the remaining genes were centered by subtracting (in log space) the median observed value, to remove any effect of the amount of mRNA in the common reference pool. Hierarchical clustering according to the program 'Cluster' (M.Eisen; http:/ /www.microarrays.org/software) 10 was applied. The results were visualized with Treeview (http:/ /www.microarrays.org/ software).
10 Statistical analysis on microarray data was performed using Significance Analysis of Microarray data (SAM: http:/ /www-stat.stanford.edu/Btibs/SAM/ faq.html). 35 Although SAM imputes missing values, we allowed a maximum of four missing values for each gene. The fold change in expression is calculated for each gene between different groups and significance levels are indicated by the q-value. A q-value of 5% for a particular gene means that at a false significance rate of 5% this gene will still be listed as significant. A q-value of less than 5% was considered significant. If a gene was spotted more than once, the mean values of the fold change of distinct cDNAs representing the same gene were calculated and presented 7 SE including their geometric mean q-values.
Full data can be viewed at the Stanford Microarray Database 36 at http:/ /genome-www.standford.edu.microarray.
